Arovella Therapeutics (ASX:ALA) said Chairman Thomas Duthy will retire from his role, effective Tuesday, to pursue new business opportunities, according to a Monday filing with the Australian bourse.
The board has appointed Elizabeth Stoner as interim chair while the company conducts a comprehensive search for a new chair, the filing added.
The company's shares tumbled 9% in recent Monday trade.